These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12109332)

  • 1. Pharmaceutical vials with extremely high chemical inertness.
    Walther M; Rupertus V; Seemann C; Brecht J; Hormes R; Swift RW
    PDA J Pharm Sci Technol; 2002; 56(3):124-9. PubMed ID: 12109332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complexing Agents and pH Influence on Chemical Durability of Type I Molded Glass Containers.
    Biavati A; Poncini M; Ferrarini A; Favaro N; Scarpa M; Vallotto M
    PDA J Pharm Sci Technol; 2017; 71(4):306-316. PubMed ID: 28747538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Contribution to an Understanding of Complexing Agents and Salt Solutions Reaction Mechanism on Chemical Attack of Type I Molded Glass Containers.
    Biavati A; Severi G; Bisceglie F; Marchegiani M; Ferrarini A
    PDA J Pharm Sci Technol; 2019; 73(6):538-551. PubMed ID: 31101704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Leachable Study of Glass Vials to Demonstrate the Impact of Low Fill Volume.
    Hladik B; Buscke F; Frost R; Rothhaar U
    PDA J Pharm Sci Technol; 2019; 73(4):345-355. PubMed ID: 30770482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Introducing the Alba® Primary Packaging Platform. Part 2: Inorganic Extractables Evaluation.
    Chillon A; Zuccato D
    PDA J Pharm Sci Technol; 2019; 73(3):235-246. PubMed ID: 30651335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance Stability of Silicone Oxide-Coated Plastic Parenteral Vials.
    Weikart CM; Pantano CG; Shallenberger JR
    PDA J Pharm Sci Technol; 2017; 71(4):317-327. PubMed ID: 28416645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibiting Sterilization-Induced Oxidation of Large Molecule Therapeutics Packaged in Plastic Parenteral Vials.
    Vieregg JR; Martin SJ; Breeland AP; Weikart CM; Tirrell MV
    PDA J Pharm Sci Technol; 2018; 72(1):35-43. PubMed ID: 28928291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of surface properties of glass vials used as primary packaging material for parenterals.
    Ditter D; Mahler HC; Roehl H; Wahl M; Huwyler J; Nieto A; Allmendinger A
    Eur J Pharm Biopharm; 2018 Apr; 125():58-67. PubMed ID: 29331438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancing Patient Safety through the Use of a Pharmaceutical Glass Designed To Prevent Cracked Containers.
    Schaut RA; Hoff KC; Demartino SE; Denson WK; Verkleeren RL
    PDA J Pharm Sci Technol; 2017; 71(6):511-528. PubMed ID: 28928290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of primary packaging on the quality of parenteral products.
    Solomun L; Ibric S; Boltic Z; Djuric Z; Stupar B
    J Pharm Biomed Anal; 2008 Nov; 48(3):744-8. PubMed ID: 18786797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic approach for screening glass containers and elastomeric closures for use with parenteral solutions.
    White F; Koberda M; Chilamkurti R
    PDA J Pharm Sci Technol; 2008; 62(3):157-76. PubMed ID: 18661866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of the hydrolytic resistance of glass containers using pH determination. Problems and methods for the determination of the chemical resistance of the internal surface of vials].
    Rehm K
    Boll Chim Farm; 1967 Jun; 106(6):375-84. PubMed ID: 5615990
    [No Abstract]   [Full Text] [Related]  

  • 13. Delamination Propensity of Glass Containers for Pharmaceutical Use: A Round Robin Activity Looking for a Predictive Test.
    Cerdan-Diaz J; Choju K; Flynn CR; Gavioli L; Iacocca R; Meysner A; Pfeifer J; Roehl H; Rupertus V; Scarpa M; Sun H; Zhang J; Zuccato D; Guglielmi M
    PDA J Pharm Sci Technol; 2018; 72(6):553-565. PubMed ID: 29954923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Introducing the Alba
    Chillon A; Pace A; Zuccato D
    PDA J Pharm Sci Technol; 2018; 72(4):382-392. PubMed ID: 29853611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Glass containers and their chemical inertness in contact with drugs].
    Branchi G; Mecarelli E
    Farmaco Prat; 1975 Dec; 30(12):605-14. PubMed ID: 1204817
    [No Abstract]   [Full Text] [Related]  

  • 16. Physical and chemical stability of paclitaxel infusions in different container types.
    Donyai P; Sewell GJ
    J Oncol Pharm Pract; 2006 Dec; 12(4):211-22. PubMed ID: 17156593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selection of containers and closure systems for injectable products.
    Nedich RL
    Am J Hosp Pharm; 1983 Nov; 40(11):1924-7. PubMed ID: 6650521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of glass corrosion on drug substance stability.
    Watkins MA; Iacocca RG; Shelbourn TL; Dong X; Stobba-Wiley C
    J Pharm Sci; 2014 Aug; 103(8):2456-63. PubMed ID: 24989460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability of three oral liquid drug products repackaged in unit dose containers.
    Christensen JM; Lee RY; Parrott KA
    Am J Hosp Pharm; 1983 Apr; 40(4):612-5. PubMed ID: 6846370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Container-content compatibility studies: a pharmaceutical team's integrated approach.
    Laschi A; Sehnal N; Alarcon A; Barcelo B; Caire-Maurisier F; Delaire M; Feuilloley M; Genot S; Lacaze C; Pisarik L; Smati C
    PDA J Pharm Sci Technol; 2009; 63(4):285-93. PubMed ID: 20088243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.